Inside Gamma Delta T Cells with TC BioPharm’s CEO, Bryan Kobel

<p>TC BioPharm&apos;s CEO Bryan Kobel explains gamma delta t cells (GDT) in depth as well as the advantages of using GDT cells as a cell therapy vehicle. He discusses why the publicly-traded, clinical-stage cell therapy company conducts and manages all clinical trials in house as well as the unique challenges and benefits that come along with doing so. </p>